D&O (Directors and Officers)
-
Watford is liable for a $18.6mn fee if the Arch deal is terminated.
-
The decision follows an earlier move to shrink the book and the departure of CUO of international financial lines Tim Powell.
-
The Allianz unit says the experience of the Sars epidemic suggests general liability claims are likely to remain benign.
-
The additional capacity will go a small way to relieving a shortfall in the class, which has triggered rate rises of as much as 400%.
-
As rating soars and income dries up, clients are forced to cut limits and take on higher deductibles.
-
A memo circulated to brokers indicates the extent of the hardening underway in the London D&O market.
-
The group remains committed to the class in Bermuda and the US.
-
The broker’s Clips survey also recorded a significant acceleration in property prices.
-
The ex-Neon underwriter joins after a brief period heading up financial lines at Barents Re.
-
The carrier will be actively targeting excess lines on US-listed placements, where capacity has been shrinking.
-
The broker notes that Covid-19 will have a long-term impact on classes of business including D&O.
-
The directors’ and officers’ (D&O) insurance market is bracing for a total loss of around $600mn for claims against American-Israeli drug manufacturer Teva Pharmaceuticals.
Most Recent
-
Aon extends Clavarino contract to 2029
09 May 2025 -
Aon sets up new US property facility
09 May 2025 -
QBE boosts Q1 premiums 7% to A$8.3bn
09 May 2025 -
Daily Digest: Top news from 9 May
09 May 2025